Delivery Order SPE2DB24D1201-SPE2DB25FJBCU
Award Date
1/13/25
Potential Completion Date
2/4/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BOTOX 200 unit vials to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $23,285.20. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is for the supply of BOTOX 200 UNIT VIALS to the U.S. Department of Defense (DoD), specifically the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,910.65, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency that supports military healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $14,454.00 and a completion date of December 31, 2024. This award does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $13,971.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200-unit vials of the prescription drug Botox. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is for the delivery of BOTOX 200 unit vials to the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $23,285.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
The U.S. government awarded a delivery order contract valued at $17,463.90 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of BOTOX 200 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense (DoD) healthcare system. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $90,337.50 delivery order contract is for the supply of BOTOX 200 unit vials, with a period of performance through December 17, 2024. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $11,642.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, with an ultimate completion date of December 4, 2024. The contract was not set aside for any specific business category....
This federal contract award is a delivery order valued at $4,737.48 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100-unit vials of BOTOX, a specialty medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Botox 200 unit vials. The $20,956.68 firm-fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies...